Ghazala Rubi, Muhammad Sharjeel Ilyas, Ayesha Fahim, Faisal Hassan Shah, Zainab Javaid.
Clinical efficacy of convalescent plasma trearment in covid-19 patients.
Pak Postgrad Med J Jan ;34(1):23-7.

Background: COVID-19 is an infectious disease caused by a newly identified strain of coronavirus (SARS-CoV-2). This strain is responsible for respiratory infections in humans. Objective: The objective of this study was to analyze the clinical efficacy and safety of convalescent plasma (CP) therapy in coronavirus disease 2019 (COVID-19) cases. Methodology: This was an experimental trial of COVID-19 patients treated with convalescent plasma (CP) therapy, these patients were admitted in Lahore General Hospital, Lahore, Pakistan during April 24 to august 24, 2021. Results: Pearson correlation was applied to extract the efficacy of convalescent plasma therapy (CP). A p-value <=0.05 was considered significant. 16 out of 20 patients (80%) were completely recovered from COVID-19. Conclusion: Convalescent plasma (CP) proved to be an effective and safe therapy for confirmed cases of COVID-19. However, two critically ill patients died.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com